XBP1 and primary effusion lymphoma: In conclusion, this study suggests that targeting UPR, particularly the IRE1alpha/XBP1 axis, may represent a promising strategy against PEL and that its cytotoxic effect may be increased by combing it with autophagy inhibitors.